ICU(ICU)
ICU
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2M | $3M | $16M |
| Low | $2M | $3M | $16M |
| High | $2M | $3M | $16M |
| EBITDA Avg | $399,999 | $599,999 | $3M |
| Low | $398,211 | $597,316 | $3M |
| High | $401,788 | $602,682 | $3M |
| EBIT Avg | $399,999 | $599,999 | $3M |
| Low | $398,211 | $597,316 | $3M |
| High | $401,788 | $602,682 | $3M |
| Net Income Avg | $-76M | $-43M | $-16M |
| Low | $-76M | $-44M | $-16M |
| High | $-75M | $-43M | $-16M |
| EPS Avg | $-3.66 | $-2.09 | $-0.76 |
| Low | $-3.68 | $-2.10 | $-0.76 |
| High | $-3.64 | $-2.08 | $-0.76 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $500,000 | $500,000 |
| Low | $500,000 | $500,000 |
| High | $500,000 | $500,000 |
| EBITDA Avg | $99,999 | $99,999 |
| Low | $99,999 | $99,999 |
| High | $99,999 | $99,999 |
| EBIT Avg | $99,999 | $99,999 |
| Low | $99,999 | $99,999 |
| High | $99,999 | $99,999 |
| Net Income Avg | $-4M | $-4M |
| Low | $-4M | $-4M |
| High | $-4M | $-4M |
| EPS Avg | $-0.95 | $-0.89 |
| Low | $-0.95 | $-0.89 |
| High | $-0.95 | $-0.89 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |